W. Barlow

发表

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust.

R. Gray, M. Piccart, F. Cardoso, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

H. Linden, G. Hortobagyi, D. Tripathy, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy Use and Locoregional Recurrence Rates on SWOG 1007, a US Cooperative Group Trial Enrolling Patients with Favorable-Risk Node-Positive Breast Cancer

R. Jagsi, L. Pusztai, E. Connolly, 2022, International Journal of Radiation Oncology, Biology, Physics.